Bizarre Patents
A forehead support apparatus for resting a standing users forehead against a wall above a bathroom commode or urinal or beneath a showerhead.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8110226 | Drug formulations having inert sealed cores A drug composition comprising a coated bead is used in the manufacture of immediate release and/or controlled release drug compositions. In a specific embodiment, the bead includes an inert core of a water-soluble or water-swellable material, which has been coated w... | 02/07/2012 |
| 8101208 | Sensate compositions and delivery systems therefor The present invention includes compositions for imparting a controlled-release sensation to the oral receptor areas of a user. The oral, controlled-release compositions include a sensate and a hydrated or swollen food-grade polymer which forms a matrix with the sens... | 01/24/2012 |
| 8092836 | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly The invention relates to capsules coated with a polyelectrolyte shell and methods for the production thereof. ... | 01/10/2012 |
| 8088413 | Methods for improved cryo-chemotherapy tissue ablation The current invention relates to a process for increasing the efficacy of cancerous disease inhibiting therapeutic agents delivered to a treatment region of a tissue structure, such as a tumor. The multi-step procedure takes advantage of the resulting thermal stress... | 01/03/2012 |
| 8071133 | Oral dosage forms of water insoluble drugs and methods of making the same A method of making an oral dosage form of a water insoluble drug such as Saquinavir or Cyclosporine or Paclitaxel is carried out by: (a) providing a single phase working Solution comprising or consisting essentially of an active agent, water, a water-soluble polymer... | 12/06/2011 |
| 8067033 | Stable compositions of famotidine and ibuprofen Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments, the ibupro... | 11/29/2011 |
| 8062672 | Antibiotic product, use and formulation thereof An antibiotic product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antibiotic product being reached in less than about twelve hours after the initial release of antibiotic. In one embod... | 11/22/2011 |
| 8062671 | Oily skin preparation for external use The objective of this invention is to provide an oily external composition for skin having an excellent rough skin recovering/preventing effect, and wherein powder is well dispersed in oil. An oily external composition for skin of this invention is characterized in ... | 11/22/2011 |
| 8021690 | Solid preparation coated with a film coating layer and film coating agent The present invention provides solid preparations having two or more colors or a pattern of two or more different colors which can solve the problems of the prior art including the complexity of production processes and the low strength of solid preparations. Specif... | 09/20/2011 |
| 8017155 | Methods for encapsulation of biomacromolecules in polymers A method for encapsulating a biomacromolecule in a pore-containing polymer comprising the steps of providing an encapsulating solution containing the biomacromolecule and the pore-containing polymer; contacting the biomacromolecule with the pore-containing polymer f... | 09/13/2011 |
| 8007830 | Granule formation The present invention relates to oral granules of montelukast sodium. ... | 08/30/2011 |
| 7964218 | Granular preparations for oral administration The present invention provides an oral grain preparation comprising an agent swellable in the mouth as an active component, wherein the preparation has an inner coating layer of a water-soluble cellulose polymer and an outer coating layer of an ethylcellulose on a p... | 06/21/2011 |
| 7943179 | pH triggerable polymeric particles A drug delivery system comprising pH triggerable particles is described. The pH triggerable particles comprise and agent(s) to be delivered, which is encapsulated in a matrix comprising a pH trigger agent and a polymer. Agents including nucleic acids may be delivere... | 05/17/2011 |
| 7939106 | Process for preparing a rapidly dispersing solid drug dosage form Rapidly dispersing solid dry therapeutic dosage form comprised of a water insoluble compound existing as a nanometer or micrometer particulate solid which is surface stabilized by the presence of at least one phospholipid, the particulate solid being dispersed throu... | 05/10/2011 |
| 7939105 | Process for preparing a rapidly dispersing solid drug dosage form Rapidly dispersing solid dry therapeutic dosage form comprised of a water insoluble compound existing as a nanometer or micrometer particulate solid which is surface stabilized by the presence of at least one phospholipid, the particulate solid being dispersed throu... | 05/10/2011 |
| 7923034 | Process for producing microparticles An object of the present invention is to provide a solvent which is able to produce microparticles where content of the drug is still high and no initial burst takes place even when a drug having a low solubility in a halogenated hydrocarbon solvent is used. The pre... | 04/12/2011 |
| 7906147 | Functional associative coatings for nanoparticles Described herein are nanoparticles that are coated with a bilayer of molecules formed from surface binding molecules and amphiphatic molecules. The bilayer coating self assembles on the nanoparticles from readily available materials/molecules. The modular design of ... | 03/15/2011 |
| 7901712 | Gliclazide nanosphere and manufacturing method therefor and application thereof An novel gliclazide nanosphere, the manufacturing method therefor and the application thereof are provided in the present application is provided. The gliclazide nanosphere is prepared by reacting the solid gliclazide with a polymeric matrix for improving the dissol... | 03/08/2011 |
| 7897179 | Pharmaceutical composition containing water soluble drug The present invention is directed to a process of preparing beads coated with a water soluble drug for incorporation into a pharmaceutical composition comprising: (a) preparing a supersaturated drug solution containing a desired amount of drug, which is completely s... | 03/01/2011 |
| 7897178 | Water-swellable clay mineral laminated powder, dye/water-swellable clay mineral complex and composition comprising the same The water-swellable clay mineral laminated powder of the present invention is characterized in that a layer of ionic molecule having two or more ionic functional group is laminated on the surface of a base powder particle, and a layer of water-swellable clay mineral... | 03/01/2011 |
| 7871645 | Ion exchange resin treated to control swelling The present invention provides a method and composition for loading one or more drugs in a solution onto one or more ion exchange resin particles to form a drug-loaded resin particle. The drug-loaded resin particle is separated from the solution and dried before rec... | 01/18/2011 |
| 7838037 | Method of microencapsulation The present invention provides methods for microencapsulation of active ingredients for topical application, whereby double-layer and triple-layer microcapsules are obtained. The microcapsules protect the active ingredients, maintain their original activity througho... | 11/23/2010 |
| 7829122 | Microgranules based on active principle and method for making same The invention concerns a microgranule consisting of a core coated with at least a coating layer, said coated core comprising at least an active principle. The invention is characterised in that the core and said coating layer contain each between 80 and 95 wt. % of ... | 11/09/2010 |
| 7820204 | Drug delivery system targeting to estrogen receptor over-expressed cells A vector for targeted delivery of drugs into estrogen receptors over-expressed cells is disclosed. The vector of the present invention is mainly about an active targeting delivery carrier which consists of a plurality of nanoparticles including: (i) a plurality of t... | 10/26/2010 |
| 7803405 | Encapsulation of aqueous phase systems within microscopic volumes A means and method for preparing vesicles and freestanding two-dimensional assemblies using aqueous two-phase systems (ATPS) is described. The surface tension of the ATPS is sufficient to support the assembly of various types of particles, and provide the advantage ... | 09/28/2010 |
| 7790200 | Formulation and process for drug loaded cores The present invention relates to a controlled release pellet of metoprolol and its pharmaceutically acceptable salts that uses a water soluble or a water swellable inert starting seed or core. ... | 09/07/2010 |
| 7780990 | Combination therapeutic compositions and method of use The present invention provides pharmaceutical compositions and methods for the treatment of diabetes mellitus using combination therapy. The compositions relate to a compound selected from one or more of betaines, lipidic betaines, betaine lipids and an antidiabetic... | 08/24/2010 |
| 7771750 | Controlled release oral dosage form A once a day bupropion hydrochloride formulation is disclosed. ... | 08/10/2010 |
| 7744924 | Venlafaxine formulations and methods of preparing the same A method of forming a multi-particulate dosage form using rotary granulation is described in which polyethylene oxide is employed as s binder in a rotary granulation process. A multi-particulate oral dosage form comprises a plurality of pellets, the pellets comprisi... | 06/29/2010 |
| 7727557 | Pharmaceutical formulation containing irritant Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after ... | 06/01/2010 |
| 7722899 | Surface-treated powder and cosmetic preparation A surface-treated powder powder which is surface-treated with an acrylic/silicone copolymer having at least one hydrolyzable silyl group in the molecule, and a cosmetic material containing this powder. The surface-treated powder of this invention preferably c... | 05/25/2010 |
| 7718194 | Coated particles with prolonged release and tablets containing same The invention concerns coated particles with prolonged release, a method for preparing same and multiparticulate tablets comprising said coated particles. ... | 05/18/2010 |
| 7691412 | Prolonged release biodegradable microspheres and method for preparing same The invention concerns a method for preparing a pharmaceutical composition in the form of microspheres with prolonged release of a water-soluble active principle. The invention is characterized in that it comprises the following successive steps: dissolving an activ... | 04/06/2010 |
| 7682633 | Pharmaceutical composition Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal ... | 03/23/2010 |
| 7682632 | Tamper-resistant oral opioid agonist formulations Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is substantially not released when the dosage form is administered intact. ... | 03/23/2010 |
| 7682634 | Pharmaceutical compositions Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal ... | 03/23/2010 |
| 7670626 | Delivery of a bioactive material A solid pharmaceutical composition comprising a water-soluble bioactive material and an encapsulating material which is present in the composition in the form of continuous solid phase, and in which solid particles of the bioactive material are dispersed and encapsu... | 03/02/2010 |
| 7655259 | Delayed release carnitine A sustained release, orally administered pharmaceutical composition comprising carnitine and an acceptable pharmaceutical excipient is described for the treatment of carnitine deficiency and other carnitine responsive conditions. The sustained release formulation av... | 02/02/2010 |
| 7611731 | Mesostructured silica/block copolymer monoliths as a controlled release device and methods of manufacture The invention comprises the design, synthesis, and characterization of mesostructured silica/block copolymer composite monoliths as controlled release systems. The controlled release function is based on the formation of mesostructured silica/block copolymer archite... | 11/03/2009 |
| 7597907 | Antioxidant polymer nanocarriers for use in preventing oxidative injury The present invention is a method for encapsulating active protein in a polymeric nanocarrier. The instant method employs homogenization at subzero temperatures so that enzyme activity is retained. Enzymes which can be encapsulated by the present method include, for... | 10/06/2009 |
